dosist™ Brings Clean High Performance Gummies to Edible Category


Ryan Allway

April 20th, 2021

News


Leading all-natural cannabis brand dosist™ launches 100% vegan, fast-acting cannabis gummy collection featuring nanoblend™ technology

 

LOS ANGELESApril 20, 2021 /PRNewswire/ — Award-winning cannabis leader dosist™ today announced the launch of dosist perfomance gummies, the latest innovation in its rapidly expanding THC product portfolio. Available now in California, dosist’s fast-acting, all-natural vegan gummies were designed to completely elevate the edible category through clean organic ingredients, mouth-watering natural fruit flavors and the company’s nanoblend™ technology, which provides consumers with a faster onset and more consistent experience.

 

“We believe that making the best gummies for your health and happiness means creating products with non-GMO, plant-based, organic, vegan ingredients that work quickly and effectively,” said Jason DeLand, executive chairman and co-founder of dosist. “We spent months deciding between different flavors, textures, effects, dosages and onset speed, working with the best in culinary arts and cannabinoid sciences. We believe we have created the best performing gummy on the market.”

 

The new dosist gummy collection includes a progressive lineup of cannabis-infused flavors and formulations that cater to each consumer’s preference around flavor, potency and effect. At the forefront is Sleep, already a slumber-promoting favorite among consumers and retailers, which features a 5:1 THC to CBN ratio in a soothing blackberry lavender flavor. Alongside of Sleep, you’ll find Bliss, featuring 5 mg of THC to help you feel just the right amount of good, available in both Wildberry and Lemon Lime flavors. Also, Calm features a 1:10 THC to CBD ratio in Lemon Balm Citrus to help melt the stress away. Sleep, Bliss and Calm are all 100% plant-based, vegan, all-natural, non-GMO and feature dosist’s proprietary ‘self-microemulsifying drug delivery system’ called nanoblend. Nanoblend™ creates greater bioavailability of the cannabinoids through natural absorption in the mouth and upper stomach, resulting in faster absorption, potency precision, higher concentration, better taste and an overall elevated effect.

 

Rounding out the collection, the dosist gummy range also features the highly anticipated, vibrant and vegan Live Resin gummy, done in collaboration with live resin experts Bear Extraction House. This special partnership live resin gummy contains 10 mg of THC and boasts delicious wild orange flavors.

 

“Our track record of delivering targeted, need-state formulas via quality experiences across all tolerance levels is well established,” continued DeLand. “With our new gummies, we have done that and more, delivering delicious tasting cannabis edibles with clean, organic fruit ingredients and rapid onset technology that leaves our customers feeling exactly as they intended, when they intended it. I’m excited to share our performance gummy experience with Californians today.”

 

Product Details & Pricing:

Sleep (MSRP $21is a blackberry lavender slumber-promoting gummy. Here, dosist has blended the perfect mix of 5mg THC to 1mg CBN, resulting in an experience they promise will make you look forward to a good healthy sleep.

 

Bliss (MSRP $19is a 5mg THC-based gummy in two great flavors: wildberry and lemon lime. It’s a fast-acting, great tasting vegan gummy.

 

Calm (MSRP $21 ) is a bouquet of lemon balm citrus offered in a 1mg THC to 10mg CBD ratio. This CBD forward gummy lowers the volume, brightens the day and helps relax the mind and body.

 

Live Resin (MSRP $23in partnership with Bear Extraction House, allows for the full flavor of natural terpenes and cannabis to be expressed. This is a true live resin experience available in 10mg of THC.

 

*All dosist gummies are 100% vegan, 85% certified organic and non GMO. They contain fruit-based pectin vs. the industry’s widely used animal bi-product gelatin, and use only vegan organic cane sugar, and organic non-GMO vegan tapioca syrup vs. refined sugars.

 

The complete vegan, fast-acting dosist gummy collection is available now through dosist delivery in Los Angeles and at select retailers across California.

 

For more information, please visit: www.dosist.com/edibles.

 

About dosist
dosistTM, based in Los Angeles, California, launched in 2016 and has since become known as a disruptor in the both the cannabis and health & wellness industries. dosist was named one of Time Magazine’s Best Inventions, was recognized by Fast Company as one of the Top 10 Most Innovative Companies in the health sector, and was designated by LinkedIn as the number two Top Startups: Hottest U.S. Companies To Work For Now. dosist provides elevated consumer benefits and cannabis experiences through: their eight targeted formulations including bliss, sleep, calm, relief, arouse, bliss thc-plus, arouse thc-plus and relax thc-plus; their new live resin and liquid live resin pods launched in January 2021 in partnership with 710 Labs and Bear Extracts; and through their brand new edible THC gummy collection launched this month. Their proprietary delivery devices include their medical-grade dose pen™ rechargeable and their newly engineered dose pen™ 100, providing the best vaporization experiences on the market. For more information about dosist and its products visit the website at dosist.com and follow us on Facebook and Instagram.

 

PR Contact
dosist@gallerypr.com

SOURCE dosist

Related Links

https://www.dosist.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading